The 50 states, as well as Washington, DC, and four territories of the United States.
The agreement resolves pending litigation against Purdue Pharma, which, under the leadership of Sackler families, invented, manufactured and commercialized opioid products aggressively for decades, according to the demands. The states and cities throughout the country said they fed waves of addiction and overdose deaths.
General prosecutors in 55 states and territories have signed the historical agreement, who said it will end with the property of Purdue de los Sacklers and will prevent them from doing, selling or marketing opioids in the United States.
California, Colorado, Connecticut, Delaware, Florida, Illinois, Massachusetts, Oregon, Pennsylvania, Tennessee, Texas, Vermont, Virginia and Virginia Occidental directed the team that negotiated the agreement, which marks the major of its type that involves the opioid crises, officials said officials.
“While the families and communities of Pennsylvania suffered during an unprecedented addiction crisis, Purdue and the vacurers obtained the gigantic profits of their products,” said the Attorney General of Pennsylvania, Dave Sunday, in a statement. “This monumental agreement achieves the main priority to obtain as much money as possible as possible for prevention, treatment and recovery programs throughout the Commonwealth. My office will continue to participate with municipal leaders to ensure that millions of dollars reach each corner of the State.”
In this archive photo of February 19, 2013, Oxycontin pills are shown in a pharmacy in Montpelier, vt.
Toby Talbot/AP, file
This is a development story. Consult the updates again.
